SWA
NTUS

Sutton Wealth Advisors’s Natus Medical Inc NTUS Stock Holding History

Sutton Wealth Advisors’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-684
Closed -$22.4K – 1750
2022
Q2 		$22.4K Hold
684
– – 0.01% 636
2022
Q1 		$18K Hold
684
– – 0.01% 740
2021
Q4 		$16.2K Buy
684
+9
+1% +$222 0.01% 771
2021
Q3 		$16.9K Hold
675
– – 0.01% 749
2021
Q2 		$17.5K Hold
675
– – 0.01% 743
2021
Q1 		$17.3K Hold
675
– – 0.01% 712
2020
Q4 		$13.5K Hold
675
– – 0.01% 723
2020
Q3 		$11.6K Buy
675
+444
+192% +$8.39K 0.01% 693
2020
Q2 		$5.04K Sell
231
-323
-58% -$7.39K ﹤0.01% 883
2020
Q1 		$12.8K Hold
554
– – 0.01% 589
2019
Q4 		$18.3K Hold
554
– – 0.01% 641
2019
Q3 		$17.6K Hold
554
– – 0.01% 621
2019
Q2 		$14.2K Hold
554
– – 0.01% 677
2019
Q1 		$14.1K Buy
554
+103
+23% +$3.07K 0.01% 693
2018
Q4 		$15.3K Sell
451
-17
-4% -$553 0.01% 611
2018
Q3 		$16.7K Buy
+468
New +$16.5K 0.01% 655

Other funds holding NTUS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sutton Wealth Advisors's NTUS Position: Q3 2022 in Review

Sutton Wealth Advisors sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 684 shares — an estimated $22.4K sold.

Sutton Wealth Advisors first reported a position in NTUS in Q3 2018 and held it in 16 quarters. The position peaked at $22.4K in Q2 2022. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Sutton Wealth Advisors reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Sutton Wealth Advisors sold 684 Natus Medical Inc shares in Q3 2022, an estimated $22.4K.
  • Sutton Wealth Advisors first reported a position in Natus Medical Inc in Q3 2018 and held it in 16 quarters.
  • Sutton Wealth Advisors's Natus Medical Inc position peaked at $22.4K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Sutton Wealth Advisors's 13F filing for Q3 2022, filed 7 Nov 2023.